Martin Farlow

Dr. Farlow is Professor Emeritus of Neurology at Indiana University, Associate Co-Director of the Indiana Alzheimer’s Disease Center, Director Alzheimer Clinical Trials site and contributed to 150 clinical trials. He graduated with MD and Neurology Residency at Indiana University. He is a member of multiple societies and has 300 invited lectures. He is on the editorial boards of MedLink and Current Alzheimer Research. He has 470 abstracts, 460 peer-reviewed articles. His research focuses on clinical trials (lead on trials of tacrine, donepezil, rivastigmine, CAD106), methodology, safety, and characterizing familial dementias (Dominantly Inherited AD, Gerstmann-Straussler-Scheinker disease, and chromosome 17 related dementias.